当前位置: 首页 > 详情页

Outcomes of microcatheter-assisted trabeculotomy following failed angle surgeries in primary congenital glaucoma

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ, Beijing Tongren Hosp, Dept Ophthalmol, Beijing Tongren Eye Ctr, 1 Dongjiaominxiang St, Beijing 100730, Peoples R China; [2]Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02114 USA; [3]Beijing Anzhen Hosp, Dept Ophthalmol, Beijing, Peoples R China; [4]First Peoples Hosp Xuzhou, Dept Ophthalmol, Xuzhou, Peoples R China
出处:
ISSN:

摘要:
Purpose To report surgical outcomes of microcatheter-assisted trabeculotomy following failed angle surgeries, and compare those with no previous angle surgery, in primary congenital glaucoma (PCG). Methods The early postoperative (12 months) results of 42 eyes of 36 patients who underwent microcatheter-assisted trabeculotomy by single surgeon for PCG were retrospectively analyzed. Group 1, 20 eyes of 16 patients, had no previous angle surgery. Group 2, 22 eyes of 20 patients, had one or two previous failed angle surgeries. Success was defined as an intraocular pressure (IOP) < 21mm Hg with at least a 30% reduction from preoperative IOP with (qualified success) or without (complete success) the use of antiglaucoma medication. Results Mean IOP decreased from 31.5 +/- 7.2 mm Hg on 3 (median, range: 1-5) medications in Group 1 and 34.6 +/- 7.3 mm Hg on 3 (median, range: 1-4) medications in Group 2 preoperatively to 15.6 +/- 3.1 mm Hg on 0 (median, range: 0-4) medications in Group 1 and 16.0 +/- 4.6 mm Hg on 0 (median, range: 0-2) medications in Group 2 postoperatively at 12 months (both P<0.001), respectively. The mean percentage of IOP reduction from preoperative to last postoperative visit was 46.0 +/- 20.1% in Group 1 and 45.5 +/- 25.0% in Group 2, P= 0.947. Qualified and complete successes were comparable between Group 1 and Group 2 (qualified success: 90.0% vs 77.3%, P= 0.294; complete success: 78.9% vs 77.3%, P= 0.853). Complications were minimal. Conclusions Microcatheter-assisted trabeculotomy achieved significant pressurelowering effects with a reduction in medication use in PCG, and it represents a reasonable choice of initial and repeat surgical treatment for PCG.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2016]版:
大类 | 4 区 医学
小类 | 3 区 眼科学
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 眼科学
JCR分区:
出版当年[2015]版:
Q2 OPHTHALMOLOGY
最新[2023]版:
Q1 OPHTHALMOLOGY Q2 OPHTHALMOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2015版] 出版当年五年平均 出版前一年[2014版] 出版后一年[2016版]

第一作者:
第一作者机构: [1]Capital Med Univ, Beijing Tongren Hosp, Dept Ophthalmol, Beijing Tongren Eye Ctr, 1 Dongjiaominxiang St, Beijing 100730, Peoples R China;
通讯作者:
通讯机构: [1]Capital Med Univ, Beijing Tongren Hosp, Dept Ophthalmol, Beijing Tongren Eye Ctr, 1 Dongjiaominxiang St, Beijing 100730, Peoples R China;
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院